|
Catalogue
Number
|
Product
|
Order number / Unit
|
|
|
1550
|
Tosyl-Fallypride
|
1550.0002: 2 mg per vial
1550.0003: 3 mg per vial
1550.0004: 4 mg per vial
Please inquire for customized
filling and bulk quantities.
|
|
|
Precursor for [18F]Fallypride
|
|
|
|
|
|
|
|
|
Molar Mass: 516.65
|
|
|
C27H36N2O6S
|
|
|
[166173-74-6]
|
|
|
|
|
|
Colourless to yellowish oil packaged in dark glass crimp cap vials.
|
|
|
|
|
|
|
|
|
Purity: > 90 %
|
|
|
Certificates:
CoA; 1H NMR spectrum
|
|
|
Chemical Name:
CA index name: Benzamide, 2,3-dimethoxy-5-[3-[[(4-methylphenyl)sulfonyl]oxy]propyl]-N-[[1-(2-propenyl)-2-pyrrolidinyl]methyl]-, (S)-
|
|
|
Synonymes:
(S)-2,3-dimethoxy-5-[3-[[(4-methylphenyl)-sulfonyl]oxy]-propyl]-N-[[1-(2-propenyl)-2-pyrrolidinyl]methyl]-benzamide
|
|
|
Literature:
1. Mukherjee J. et al. Preliminary Assessment of Extrastriatal Dopamine D-2 Receptor Binding in the Rodent and Nonhuman Primat Brains Using the High Affinity Radioligand, 18F-Fallypride Nucl. Med. Biol. 1999, 26, 519-527.
|
|
|
2. Mukherjee J. et al. Fluorinated Benzamide Neuroleptics - III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-[3-[18F]fluoro-propyl)dimethoxybenzamide as an Improved Dopamine D-2 Receptor Tracer. Nucl. Med. Biol. 1995, 22, 283-296.
|
|
|
3. Mukherjee J. et al. Evaluation of d-Amphetamine Effects on the Binding of Dopamine D-2 Receptor Radioligand, 18F-Fallypride in Nonhuman Primates Using Positron Emission Tomography. Synapse 1997, 27, 1-13.
|
|
|
|
|
|
|
|
|
date of product catalogue issue:
05 April 2012
|